Poisson Regression Modelling of the Effectiveness of the Meningococcal B Vaccine (MeNZB)

Updated results to December 2008

Published online: 
30 October 2011

New Zealand experienced a prolonged epidemic of Meningococcal B disease starting in 1991 and peaking in 2001. In response, a strain-specific meningococcal B vaccine (MeNZB) was developed and offered through a national programme to all New Zealand children and teenagers under the age of 20 years from July 2004 to June 2006. MeNZB continued to be offered to babies until 1 June 2008. 

This report updates findings from earlier studies assessing the impact of the MeNZB vaccine, and forms the basis of published study (Arnold R, et al. 2011. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand. Vaccine. 29(40): 7100–06).

Publishing information

  • Date of publication:
    30 October 2011
  • Citation:
    Arnold R. 2011. Poisson Regression Modelling of the Effectiveness of the Meningococcal B Vaccine (MeNZB): Updated results to December 2008. Wellington: Victoria University of Wellington.
  • Ordering information:
    Only soft copy available to download
Back to top